Indegene Launches US-based Healthcare Business Division Focused on Payer and Provider Markets Indegene Healthcare will focus on Engagement, Quality, Big-Data, and Payment Transformation driven by US health reform.
ISELIN, N.J., Nov. 6, 2013 /PRNewswire-iReach/ -- Indegene, a leading global life sciences, pharmaceutical, and healthcare services organization, today announced its formal entry into the US Payer and Provider Market through Indegene Healthcare (www.indegenehealthcare.com) —the company's new healthcare business division. Indegene is a leading global service provider with a presence across 14 locations, including the United States, United Kingdom, Switzerland, India, and China, with more than 1200 employees across the world. Indegene Healthcare will leverage the company's rich clinical and scientific expertise, engagement and analytics platforms, robust proprietary IP portfolio, and a global asset base to enable payers and providers thrive in the changing healthcare environment.
As the US healthcare industry continues to transform, driven by the US health reform, significant changes are underway, including increasing consumer focus, pay for performance, quality and outcomes measurement, as well as risk management. Dr Rajesh Nair, President, Indegene said, "Our solutions for the US healthcare market draw upon our significant clinical domain expertise, proprietary consumer and patient frameworks, multichannel assets, as well as a robust data analytics foundation. We have made significant investments building out a comprehensive suite of proprietary products and solutions in the areas of Patient and Member Engagement, Quality Improvement, Health Reform Transformation Support, Care Management, and Analytics."
Headquartered in Iselin, NJ, Indegene Healthcare will focus on customers across North America, and existing payer and provider customers will now be serviced through Indegene Healthcare. According to Manish Gupta, CEO, Indegene, "Indegene Healthcare has embedded, within the division, multiple IP and delivery capabilities, including Clinical and Analytics expertise, Multichannel Engagement platforms, as well as an optional hybrid delivery structure to provide a scalable model. We expect our customers to benefit from this integrated approach and take full strategic advantage of the changes in the marketplace."
The company also announced the imminent launch of several specialized offerings, including MarketAccelerate™—a multichannel engagement solution for new customer acquisition for plans and health exchanges; StarEnhance™—a comprehensive quality and STAR ratings improvement solution for Medicare Advantage plans; and CustomerNgage™—a fully integrated multichannel customer and member engagement platform. Dr Nair added, "These specialized solutions and platforms give clients the unique ability to run integrated programs that bring together behavioral content, clinical understanding, deep analytics, and an enterprise platform approach to improving business and health outcomes."
About Indegene Healthcare
Indegene Healthcare is the healthcare business division of Indegene, a leading global provider of Clinical, Commercial, and Marketing solutions to global life science, pharmaceutical, and healthcare organizations. Indegene Healthcare leverages rich clinical and scientific expertise, proprietary engagement and analytics platforms, a robust IP portfolio, and global assets that enable payers and providers thrive in the changing healthcare environment through accelerated transformation, increased customer focus, and better business and health outcomes.
To learn more about Indegene Healthcare, visit us at www.indegenehealthcare.com.
Media Contact: Ann Marie Craggan, Indegene, +1 732.750.2901, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Indegene Healthcare